A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results

Gynecologic Oncology

Volumn 138, Issue 3, 2015, Pages 573-578

  Schiffman, Mark ^a   Vaughan, Laurence M ^b   Raine Bennett, Tina R ^c   Castle, Philip E ^d   Katki, Hormuzd A ^a   Gage, Julia C ^a   Fetterman, Barbara ^e   Befano, Brian ^f   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BD Diagnostics   (United States)

^c DIVISION OF RESEARCH   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e KAISER PERMANENTE   (United States)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

ASC US; Cervical screening; HPV testing; Triage

Indexed keywords

ADULT; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CANCER RISK; CANCER SCREENING; COLPOSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRAL CLEARANCE; VIRUS TYPING; WART VIRUS; GENETICS; GENOTYPE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROCEDURES; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADULT; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84941420178     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.06.040     Document Type: Article

References (18)

1. M. Schiffman, P.E. Castle, J. Jeronimo, A.C. Rodriguez, and S. Wacholder Human papillomavirus and cervical cancer Lancet 370 2007 890 907
2. L.S. Massad, M.H. Einstein, W.K. Huh, H.A. Katki, W.K. Kinney, M. Schiffman, and et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors Obstet. Gynecol. 121 2013 829 846
3. D. Saslow, D. Solomon, H.W. Lawson, M. Killackey, S.L. Kulasingam, J. Cain, and et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer CA Cancer J. Clin. 62 3 2012 147 172
4. W.K. Huh, K.A. Ault, D. Chelmow, D.D. Davey, R.A. Goulart, F.A. Garcia, and et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance Obstet. Gynecol. 123 1 2014 49 56
5. H.A. Katki, M. Schiffman, P.E. Castle, B. Fetterman, N.E. Poitras, T. Lorey, and et al. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines J. Low. Genit. Tract Dis. 17 2013 S28 S35
6. R. Nayar, and D. Solomon Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project CytoJournal 1 2004 4
7. P. Guan, R. Howell-Jones, N. Li, L. Bruni, S. de Sanjose, S. Franceschi, and et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer Int. J. Cancer 131 10 2012 2349 2359
8. V. Bouvard, R. Baan, K. Straif, Y. Grosse, B. Secretan, F. El Ghissassi, and et al. A review of human carcinogens - Part B: biological agents Lancet Oncol. 10 2009 321 322
9. P.E. Castle, B. Fetterman, N. Poitras, T. Lorey, R. Shaber, and W. Kinney Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting Obstet. Gynecol. 113 2009 595 600
10. M. Schiffman, R.D. Burk, S. Boyle, T. Raine-Bennett, H.A. Katki, J.C. Gage, and et al. A study of genotyping for the management of human papillomavirus-positive, cytology-negative cervical screening results J. Clin. Microbiol. 53 1 2015 52 59
11. B.J. LaMere, J. Kornegay, B. Fetterman, M. Sadorra, J. Shieh, and P.E. Castle Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort J. Virol. Methods 146 2007 80 85
12. P.E. Castle, E.C. Gutierrez, S.V. Leitch, C.E. Maus, R.A. McMillian, W.A. Nussbaumer, and et al. Evaluation of a new DNA test for detection of carcinogenic human papillomavirus J. Clin. Microbiol. 49 2011 3029 3032
13. T.C. Wright Jr., M.H. Stoler, P.M. Agreda, G.H. Beitman, E.C. Gutierrez, J.M. Harris, and et al. Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens Am. J. Clin. Pathol. 142 2014 43 50
14. S. de Sanjose, W.G. Quint, L. Alemany, D.T. Geraets, J.E. Klaustermeier, B. Lloveras, and et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol. 11 2010 1048 1056
15. J. Cuzick, L. Cadman, D. Mesher, J. Austin, L. Ashdown-Barr, L. Ho, and et al. Comparing the performance of six human papillomavirus tests in a screening population Br. J. Cancer 108 2013 908 913
16. M. Arbyn, P.J. Snijders, C.J. Meijer, H. Berkhof, K. Cuschieri, B.J. Kocjan, and et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015
17. J.C. Gage, M. Schiffman, D. Solomon, C.M. Wheeler, P.E. Gravitt, P.E. Castle, and et al. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities Cancer Epidemiol. Biomarkers Prev. 22 2013 1095 1101
18. P.M. Agreda, G.H. Beitman, E.C. Gutierrez, J.M. Harris, K.R. Koch, W.D. LaViers, and et al. Analytical and clinical performance of the BD Onclarity™ HPV assay on the BD Viper(tm) LT system J. Clin. Virol. 2015 (submitted for publication)